Comparison
Methylene Blue vs N-Acetyl Cysteine
Side-by-side of Methylene Blue and N-Acetyl Cysteine. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Methylene Blue
Methylene blue as a nootropic: low-dose cognitive enhancement, mitochondrial electron cycling, brain oxygen uptake, SSRI interaction risk, typical 0.5 to 4 mg.
N-Acetyl Cysteine
NAC supplement benefits cover glutathione synthesis, liver and antioxidant support, and hangover recovery. Evidence strongest at 1200-2400 mg/day.
Effects at a glance
Methylene Blue
- •FDA approved for methemoglobinemia and ifosfamide-induced encephalopathy
- •Mitochondrial electron-transport support at low doses (0.5 to 4 mg/kg) via cytochrome c shuttle
- •Potent MAO-A inhibitor; serotonin syndrome risk with SSRIs, SNRIs, MAOIs, fentanyl, tramadol, St John's wort
- •Causes harmless blue-green urine and sweat coloration; useful adherence marker
- •G6PD deficiency is an absolute contraindication; can trigger massive hemolysis
- •Cognitive-enhancement evidence is preliminary, mostly preclinical and small fMRI trials
N-Acetyl Cysteine
- •Replenishes intracellular glutathione by supplying cysteine, the rate-limiting amino acid for synthesis
- •First-line antidote for acetaminophen toxicity, restoring hepatic glutathione before fulminant injury occurs
- •Reduces sputum viscosity in chronic bronchitis and COPD at 600 to 1200 mg/day over months
- •Modest symptom reductions in OCD and trichotillomania at 1200 to 2400 mg/day across small RCTs
- •Mixed evidence for psychiatric adjunct use in bipolar depression and schizophrenia negative symptoms
- •Inhaled forms can trigger bronchospasm in active asthma; oral use is the standard biohacker route
Side-by-side
| Attribute | Methylene Blue | N-Acetyl Cysteine |
|---|---|---|
| Category | pharmaceutical | supplement |
| Also known as | Methylthioninium chloride, Provayblue, tetramethylthionine chloride | NAC |
| Half-life (hr) ↗ | 5.5 | 5.6 |
| Typical dose (mg) ↗ | 70 | 1200 |
| Dosing frequency | 1 to 3 times daily for cognitive use; single IV dose for methemoglobinemia | 1 to 3 times daily, split dosing preferred |
| Routes | oral, intravenous | oral, iv |
| Onset (hr) | 1 | 1 |
| Peak (hr) | 1.5 | 2 |
| Molecular weight | 319.85 | 163.19 |
| Molecular formula | C16H18ClN3S | C5H9NO3S |
| Mechanism | Mitochondrial electron carrier at low doses (cytochrome c shuttle to complex IV) and methemoglobin reductase substrate at higher doses; potent MAO-A inhibitor across the dose range. | Deacetylated to cysteine, the rate-limiting precursor for glutathione synthesis; also directly scavenges reactive oxygen species and modulates glutamate signaling. |
| Legal status | Prescription (injectable, FDA approved); supplement form (oral) widely available; not scheduled | OTC in most jurisdictions; restricted periods in US history (FDA reclassified 2022) |
| WADA status | allowed | allowed |
| DEA / Rx | Not scheduled in the US | OTC supplement (US, post-2022); Rx indications also exist (acetaminophen overdose, mucolytic) |
| Pregnancy | Contraindicated | Used clinically in pregnancy for specific indications; consult clinician |
| CAS | 61-73-4 | 616-91-1 |
| PubChem CID | 6099 | 12035 |
| Wikidata | Q409021 | Q413299 |
Safety profile
Methylene Blue
Common side effects
- blue-green urine and sweat
- skin and oral mucosa staining
- GI upset
- headache
- dizziness
Contraindications
- G6PD deficiency
- pregnancy
- concurrent serotonergic medication
- severe renal impairment
- infants under 6 months
Interactions
- SSRIs and SNRIs: serotonin syndrome, potentially fatal(major)
- MAOIs: additive MAO inhibition, serotonin syndrome risk(major)
- fentanyl, tramadol, meperidine: serotonin syndrome risk(major)
- dextromethorphan: serotonin syndrome risk(major)
- St John's wort: serotonin syndrome risk(major)
- lithium: additive serotonergic risk(major)
N-Acetyl Cysteine
Common side effects
- sulfur-like taste or odor
- nausea
- flatulence
- diarrhea
Contraindications
- active asthma attack (inhaled form can trigger bronchospasm)
- known NAC hypersensitivity
Interactions
- nitroglycerin: potentiates vasodilation, risk of hypotension and headache(moderate)
- activated charcoal: reduces NAC absorption when used for acetaminophen overdose(moderate)
- anticoagulants: theoretical additive antiplatelet effect at high doses(minor)
Which Should You Take?
N-Acetyl Cysteine comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC, oral dosing, with a Tier-A outcome catalogued. Methylene Blue is the right call when one of the conditionals below applies.
- → If your priority is focus or working memory, pick Methylene Blue.
- → If your priority is mitochondrial function, pick Methylene Blue.
- → If your priority is healthspan extension, pick N-Acetyl Cysteine.
- → If your priority is post-training recovery, pick N-Acetyl Cysteine.
Edge case: If you want to avoid controlled substance, N-Acetyl Cysteine is the more accessible choice.
Default choice: N-Acetyl Cysteine. Wider use case, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Methylene Blue only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Methylene Blue and N-Acetyl Cysteine?
Methylene Blue and N-Acetyl Cysteine differ in category (pharmaceutical vs supplement), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Methylene Blue or N-Acetyl Cysteine?
Methylene Blue half-life is 5.5 hours; N-Acetyl Cysteine half-life is 5.6 hours.
Can you stack Methylene Blue with N-Acetyl Cysteine?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper